646 related articles for article (PubMed ID: 15700631)
41. Pathogenesis of water and sodium retention in cirrhosis.
Martin PY; Schrier RW
Kidney Int Suppl; 1997 Jun; 59():S43-9. PubMed ID: 9185104
[TBL] [Abstract][Full Text] [Related]
42. Hepatorenal syndrome.
Cárdenas A; Gines P
Clin Liver Dis; 2006 May; 10(2):371-85, ix-x. PubMed ID: 16971267
[TBL] [Abstract][Full Text] [Related]
43. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J
Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036
[No Abstract] [Full Text] [Related]
44. Hepatorenal syndrome: definition, pathophysiology, clinical features and management.
Bataller R; Sort P; Ginès P; Arroyo V
Kidney Int Suppl; 1998 May; 66():S47-53. PubMed ID: 9573573
[No Abstract] [Full Text] [Related]
45. [Therapy of hepatorenal syndrome].
Walter E
Praxis (Bern 1994); 1997 Jan; 86(4):102-3. PubMed ID: 9064719
[TBL] [Abstract][Full Text] [Related]
46. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
Torre A; Terra C; Guevara M; Ginès P
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
[No Abstract] [Full Text] [Related]
47. Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.
Solà E; Ginès P
Dig Dis; 2015; 33(4):534-8. PubMed ID: 26159270
[TBL] [Abstract][Full Text] [Related]
48. Pathogenesis and management of the hepatorenal syndrome.
Laffi G; La Villa G; Gentilini P
Semin Liver Dis; 1994 Feb; 14(1):71-81. PubMed ID: 8016664
[No Abstract] [Full Text] [Related]
49. Organ interactions in the hepatorenal syndrome.
Neuschwander-Tetri BA
New Horiz; 1994 Nov; 2(4):527-44. PubMed ID: 7804802
[TBL] [Abstract][Full Text] [Related]
50. Arterial hypertension and chronic liver disease.
Henriksen JH; Møller S
Minerva Med; 2005 Aug; 96(4):233-46. PubMed ID: 16179891
[TBL] [Abstract][Full Text] [Related]
51. Pathogenesis and treatment of hepatorenal syndrome.
Arroyo V; Fernandez J; Ginès P
Semin Liver Dis; 2008 Feb; 28(1):81-95. PubMed ID: 18293279
[TBL] [Abstract][Full Text] [Related]
52. [Hepatorenal syndrome].
Mancini E
G Ital Nefrol; 2012; 29(5):563-78. PubMed ID: 23117737
[TBL] [Abstract][Full Text] [Related]
53. Ascites and Hepatorenal Syndrome.
Adebayo D; Neong SF; Wong F
Clin Liver Dis; 2019 Nov; 23(4):659-682. PubMed ID: 31563217
[TBL] [Abstract][Full Text] [Related]
54. [Hepatorenal syndrome].
Pŭrvanov P
Khirurgiia (Sofiia); 2002; 58(2):34-9. PubMed ID: 12515019
[TBL] [Abstract][Full Text] [Related]
55. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
56. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
Guevara M; Ginès P; Fernández-Esparrach G; Sort P; Salmerón JM; Jiménez W; Arroyo V; Rodés J
Hepatology; 1998 Jan; 27(1):35-41. PubMed ID: 9425914
[TBL] [Abstract][Full Text] [Related]
57. Hepatorenal syndrome: a review.
Testino G; Ferro C
Hepatogastroenterology; 2010; 57(102-103):1279-84. PubMed ID: 21410072
[TBL] [Abstract][Full Text] [Related]
58. [The pathophysiology of ascites formation in cirrhosis of the liver].
Benjaminov FS
Harefuah; 2002 Aug; 141(8):721-5, 760. PubMed ID: 12222138
[TBL] [Abstract][Full Text] [Related]
59. Hepatorenal syndrome: a critical update.
Wadei HM
Semin Respir Crit Care Med; 2012 Feb; 33(1):55-69. PubMed ID: 22447261
[TBL] [Abstract][Full Text] [Related]
60. [Hepatorenal syndrome].
Bosma JW; van Meyel JJ; Siegert CE
Ned Tijdschr Geneeskd; 2010; 154():A1355. PubMed ID: 20456764
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
